open access

Online first
Editorial
Published online: 2022-06-23
Get Citation

Contrast-induced nephropathy in acute coronary syndromes: Causal or casual?

Marco Legnazzi1, Davide Capodanno1
DOI: 10.33963/KP.a2022.0158
·
Pubmed: 35735073
Affiliations
  1. Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico “G. Rodolico — Vittorio Emanuele”, University of Catania, Catania, Italy

open access

Online first
Editorial
Published online: 2022-06-23

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Contrast-induced nephropathy in acute coronary syndromes: Causal or casual?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Editorial

Published online

2022-06-23

Page views

30

Article views/downloads

33

DOI

10.33963/KP.a2022.0158

Pubmed

35735073

Authors

Marco Legnazzi
Davide Capodanno

References (12)
  1. Legnazzi M, Agnello F, Capodanno D. Prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Kardiol Pol. 2020; 78(10): 967–973.
  2. Valle JA, McCoy LA, Maddox TM, et al. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2017; 10(4).
  3. Ehrmann S, Quartin A, Hobbs BP, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017; 43(6): 785–794.
  4. McDonald JS, McDonald RJ, Williamson EE, et al. Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med. 2017; 43(6): 774–784.
  5. McDonald JS, McDonald RJ, Comin J, et al. Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology. 2013; 267(1): 119–128.
  6. Saad M, Karam B, Faddoul G, et al. Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III-V, and ESRD. Int J Nephrol Renovasc Dis. 2016; 9: 5–10.
  7. Szummer K, Lundman P, Jacobson SH, et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med. 2010; 268(1): 40–49.
  8. Guillon B, Ecarnot F, Marcucci C, et al. Incidence, predictors, and impact on six-month mortality of three different definitions of contrast-induced acute kidney injury after coronary angiography. Am J Cardiol. 2018; 121(7): 818–824.
  9. Tsai TT, Patel UD, Chang TI, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014; 7(1): 1–9.
  10. Rakowski T, Dziewierz A, Węgiel M, et al. Risk factors of contrast induced nephropathy in patients with acute coronary syndromes. Kardiol Pol. 2022 [Epub ahead of print].
  11. O'Sullivan ED, Hughes J, Ferenbach DA. Renal aging: causes and consequences. J Am Soc Nephrol. 2017; 28(2): 407–420.
  12. Mehran R, Owen R, Chiarito M, et al. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet. 2021; 398(10315): 1974–1983.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl